Full-Time

Senior Director

Corporate Communications

Confirmed live in the last 24 hours

Vir Biotechnology

Vir Biotechnology

501-1,000 employees

Develops monoclonal antibodies for infectious diseases

AI & Machine Learning
Biotechnology

Compensation Overview

$217.5k - $318kAnnually

Senior

No H1B Sponsorship

San Francisco, CA, USA

Requires onsite presence in San Francisco for four days per week.

Category
Public Health
Biology Lab & Research
Biology & Biotech
Required Skills
Communications
Social Media
Requirements
  • Bachelors' degree with a minimum of 12 years of professional experience in Communications in the pharmaceutical/biotech area is required.
  • Demonstrated experience crafting and executing successful traditional media, social media, and internal communications strategies.
  • Strong written skills in corporate and scientific content.
  • Experience supporting senior leaders with executive communications and thought leadership strategies.
  • Demonstrated ability to collaborate, facilitate, and organize across multiple groups and levels of an organization, including direct collaboration with C-suite colleagues.
  • Understanding of SEC and FDA regulations affecting communications.
  • Must be located in the San Francisco area.
Responsibilities
  • Partner with the SVP of Corporate Communications to define corporate communication strategies that support business objectives and convey the unique value of Vir and its platforms and programs.
  • Develop PR materials, including press releases, Q&As, website content, executive talking points, fact sheets, etc., in collaboration with colleagues in Investor Relations, Legal, Alliance Management, Business Development and other parts of the organization.
  • Build and enhance relationships with external media outlets including news, business, and industry trade publications, with both traditional and digital media; garner local, regional and national coverage of Vir to meet objectives.
  • Partner with Human Resources, Employee Resource Groups and other important internal stakeholders to drive alignment in communication across the organization.
  • Work in partnership with R&D Communications to develop multi-channel strategies to share stories of Vir's impact and potential to help people living with a range of infectious diseases and cancers.
  • Help drive Vir's website and social media channel strategies and content.
  • Identify external opportunities, including media interviews, speaking engagements at industry conferences, and other forums to showcase Vir thought leadership.
  • Actively manage and direct external agency partners and drive the best value from these relationships.

Vir Biotechnology develops treatments for infectious diseases by harnessing the immune system, using a proprietary platform for monoclonal antibodies (mAbs) combined with machine learning and artificial intelligence. Their pipeline includes clinical candidates for hepatitis B, hepatitis delta, and HIV, as well as monoclonal antibodies targeting influenza, COVID-19, and human papillomavirus. What distinguishes Vir from competitors is its collaboration with industry leaders and organizations to expedite scientific advancements. The company's goal is to transform lives by addressing unmet medical needs.

Company Stage

Grant

Total Funding

$640.6M

Headquarters

San Francisco, California

Founded

2016

Growth & Insights
Headcount

6 month growth

2%

1 year growth

5%

2 year growth

8%
Simplify Jobs

Simplify's Take

What believers are saying

  • Recent bullish quarterly reports and increased analyst estimates suggest strong financial performance.
  • Significant investments, such as the $214,000 from Diversified Trust Co, indicate confidence in Vir's future prospects.
  • Presentations at high-profile conferences like J.P. Morgan's Annual Healthcare Conference and AASLD's The Liver Meeting® enhance Vir's visibility and credibility in the biotech community.

What critics are saying

  • Recent layoffs and facility shutdowns indicate potential financial instability and operational challenges.
  • The resignation of key executives, including the CFO and Chief Medical Officer, could lead to strategic and leadership uncertainties.

What makes Vir Biotechnology unique

  • Vir Biotechnology's focus on leveraging immunology expertise to engineer human antibodies into powerful medicines sets it apart from competitors.
  • Their rapid growth, as evidenced by being ranked the fastest-growing company in North America on the 2023 Deloitte Technology Fast 500, highlights their market impact.
  • Vir's ongoing Phase 2 trials for chronic hepatitis delta and B demonstrate their commitment to addressing unmet medical needs with innovative therapies.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Comprehensive healthcare coverage

Employer matched 401(k)

Employee stock purchase plan

Childcare assistance

Tuition reimbursement